ESTA News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$1.76B

Volume

235.74K

Next Earnings

November 4th

Chart Financials Earnings News About Insider Filings

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.Hedge fund JW Asset Management sold 90,533 shares of Establishment Labs (ESTA) between May 26-28, 2026, generating approximately $6.64 million at a weighted average price of $73.31 per share. The sale reduced the fund's ownership below the 10% threshold, though it retained nearly 3 million shares, suggesting continued bullish sentiment. The timing coincided with strong company performance, including 45% year-over-year revenue growth and inclusion in the Russell 2000 Index.The Motley Fool · Jul 5, 2026

ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the StoryEstablishment Labs founder Juan José Chacón Quirós sold 105,000 shares worth $7.9 million on May 6, 2026, but the timing coincided with earnings day due to a pre-scheduled 10b5-1 plan adopted in December 2025. The real story is the company's strong Q1 performance: US revenue grew 13.3% to $19.6 million, the company posted its third consecutive quarter of positive adjusted EBITDA, and management raised full-year guidance while targeting free cash flow positive in H2 2026.The Motley Fool · May 12, 2026

Breast Implants Market to Surpass USD 5.62 Billion by 2034, Driven by Rising Breast Cancer Cases and Aesthetic Surgery DemandThe global breast implants market is projected to grow from USD 2.93 billion in 2025 to USD 5.62 billion by 2034, driven by rising breast cancer cases and aesthetic surgery demand, with North America leading market share and Asia Pacific expected to witness fastest growth.GlobeNewswire Inc. · Nov 11, 2025

[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.GlobeNewswire Inc. · Jan 31, 2025

Establishment Labs CEO sells over $300k in company stock By Investing.com - Investing.com AustraliaEstablishment Labs CEO Juan Jose Chacon Quiros sold over $300,000 worth of company stock under a pre-arranged trading plan. The company has seen recent developments, including an expected FDA clearance for its Motiva implants and revenue growth, but also faces challenges with profitability.Investing.com · Jul 3, 2024

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.Zacks Investment Research · Jun 25, 2024

The Analyst Landscape: 5 Takes On Establishment Labs Hldgs5 analysts have expressed a variety of opinions on Establishment Labs Hldgs (NASDAQ:ESTA) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $59.6, a high estimate of $65.00, and a low estimate of $53.00. This current average reflects an increase of 16.86% from the previous average price target of $51.00. Deciphering Analyst Ratings: An In-Depth Analysis A comprehensive examination of how financial experts perceive Establishment Labs Hldgs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Joanne Wuensch Citigroup Maintains Neutral $60.00 $60.00 Joanne Wuensch Citigroup Raises Buy $60.00 $49.00 Anthony Petrone Mizuho Raises Buy $65.00 $50.00 Joshua Jennings TD Cowen Raises Outperform $60.00 $50.00 Allen Gong JP Morgan Raises Overweight $53.00 $46.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information ...Full story available on Benzinga.comBenzinga · May 22, 2024

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue EstimatesEstablishment Labs (ESTA) delivered earnings and revenue surprises of 10.77% and 4.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 8, 2024

Key Takeaways From Establishment Labs Hldgs Analyst RatingsIn the preceding three months, 4 analysts have released ratings for Establishment Labs Hldgs (NASDAQ:ESTA), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 0 0 0 Analysts have recently evaluated Establishment Labs Hldgs and provided 12-month price targets. The average target is $56.25, accompanied by a high estimate of $65.00 and a low estimate of $47.00. Witnessing a positive shift, the current average has risen by 15.57% from the previous average price target of $48.67. Investigating Analyst Ratings: An Elaborate Study In examining recent analyst actions, we gain insights into how financial experts perceive Establishment Labs Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Anthony Petrone Mizuho Raises Buy $65.00 $50.00 Joshua Jennings TD Cowen Raises Outperform $60.00 $50.00 Allen Gong JP Morgan Raises Overweight $53.00 $46.00 George Sellers Stephens & Co. Maintains Overweight $47.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information provides a snapshot ...Full story available on Benzinga.comBenzinga · Apr 1, 2024

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million. Butterfly Network shares dipped 21.7% to $1.1588 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of compounds. Societal CDMO, Inc. (NASDAQ: SCTL) shares climbed 132.7% to $1.07 as the company agreed to be acquired by CoreRx, Inc. Volcon, Inc. (NASDAQ: VLCN) gained 55.4% to $1.8802 after surging around 39% on Wednesday. Sidus Space, Inc. (NASDAQ: SIDU) climbed 39.7% to $7.78. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 36.4% to $2.1008. Ocean Biomedical announced joint venture partner, Virion Therapeutics to present clinical study data at 2024 APASL Global Liver Meeting. Inseego Corp. (NASDAQ: INSG) rose 34.5% to $3.00. Vertex, Inc. (NASDAQ: VERX) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance. iHeartMedia, Inc. (NASDAQ: IHRT) rose 29.1% to $2.93 following fourth-quarter results. Agrify Corporation (NASDAQ: AGFY) gained 27% to $0.6161. Agrify announced a $3.4 million sales order from New Jersey woman-owned business HarvestWorks Farm. Renalytix Plc (NASDAQ: RNLX) climbed 26.5% to $1.05 after the company announced that effective Mar. 1, the US approved adding the company's kidneyintelX.dkd to its 10-year Governmentwide Acquisition Contract. Tutor Perini Corporation (NYSE: TPC) gained 26% to $11.64 following fourth-quarter results. Bright Scholar Education Holdings Limited (NYSE: BEDU) gained 25.3% to $2.3178. C3.ai, Inc. (NYSE: AI) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results. Sterling Check Corp. (NASDAQ: STER) jumped 24.6% to $15.49 after the company agreed to be acquired by First Advantage for approximately $2.2 billion, including outstanding debt. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 24% to $2.00. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Revance Therapeutics, Inc. (NASDAQ: RVNC) jumped 24% to $7.02 after the company reported better-than-expected quarterly financial results. Latham Group, Inc. (NASDAQ: SWIM) climbed 22.8% to $3.36. Avidity Biosciences, Inc. (NASDAQ: RNA) jumped 22.5% to $18.70. Avidity Biosciences announced an oversubscribed $400 million private placement. Pure Storage, Inc. (NYSE: PSTG) rose 21.9% to $51.35 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. ...Benzinga · Feb 29, 2024

ESTAEstablishment Labs Holdings Inc.

ESTA

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ESTA yet.

Related Tickers

Earnings

Mkt Cap

$1.76B

Volume

235.74K

Next Earnings

November 4th